We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+23.69%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$6.79B
AUM Growth
+$377M
Cap. Flow
-$743M
Cap. Flow %
-10.93%
Top 10 Hldgs %
13.56%
Holding
361
New
33
Increased
100
Reduced
180
Closed
46

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$50.8M
2
DRI icon
Darden Restaurants
DRI
+$42M
3
PH icon
Parker-Hannifin
PH
+$41M
4
COR icon
Cencora
COR
+$26.6M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$25.7M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$56M
2
T icon
AT&T
T
+$48.7M
3
GILD icon
Gilead Sciences
GILD
+$48.6M
4
QDEL icon
QuidelOrtho
QDEL
+$36.3M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$32.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Financials 15.82%
3 Technology 13.99%
4 Industrials 13.07%
5 Consumer Discretionary 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
151
Abbott
ABT
$189B
$19.2M 0.28%
209,735
-50,268
-19% -$4.54M
JAZZ icon
152
Jazz Pharmaceuticals
JAZZ
$16.2B
$19.1M 0.28%
173,489
-25,208
-13% -$2.79M
ZBRA icon
153
Zebra Technologies
ZBRA
$18.1B
$19M 0.28%
74,061
-46,360
-38% -$10.9M
KSS icon
154
Kohl's
KSS
$2.1B
$18.8M 0.28%
+906,599
New +$17.5M
CATM
155
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$18.8M 0.28%
782,505
-128,600
-14% -$2.88M
BEAT
156
DELISTED
BioTelemetry, Inc.
BEAT
$18.5M 0.27%
408,309
-80,148
-16% -$3.59M
MMSI icon
157
Merit Medical Systems
MMSI
$5.45B
$18.4M 0.27%
403,613
-110,835
-22% -$4.47M
PNFP icon
158
Pinnacle Financial Partners Inc
PNFP
$16B
$18.2M 0.27%
+432,950
New +$17.2M
MAA icon
159
Mid-America Apartment Communities
MAA
$15.3B
$18.2M 0.27%
158,406
-43,536
-22% -$4.9M
BLMN icon
160
Bloomin' Brands
BLMN
$955M
$18M 0.27%
1,688,525
-21,451
-1% -$222K
RP
161
DELISTED
RealPage, Inc.
RP
$17.9M 0.26%
275,755
-188,874
-41% -$11.9M
ARNA
162
DELISTED
Arena Pharmaceuticals Inc
ARNA
$17.9M 0.26%
+284,321
New +$15.6M
LIN icon
163
Linde
LIN
$226B
$17.8M 0.26%
84,065
-6,736
-7% -$1.3M
AMED
164
DELISTED
Amedisys
AMED
$17.7M 0.26%
88,942
-141,193
-61% -$26.3M
LW icon
165
Lamb Weston
LW
$7.22B
$17.6M 0.26%
274,733
-68,879
-20% -$4.16M
OPCH icon
166
Option Care Health
OPCH
$3.64B
$17.2M 0.25%
1,241,208
-68,250
-5% -$903K
AXTA icon
167
Axalta
AXTA
$7.97B
$16.7M 0.25%
739,670
-16,240
-2% -$332K
AJRD
168
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$16.7M 0.25%
420,446
-28,193
-6% -$1.17M
IONS icon
169
Ionis Pharmaceuticals
IONS
$9.32B
$15.9M 0.23%
269,660
-74,367
-22% -$4.14M
WTFC icon
170
Wintrust Financial
WTFC
$10.9B
$15.9M 0.23%
364,330
+37,361
+11% +$1.49M
LRCX icon
171
Lam Research
LRCX
$389B
$15.8M 0.23%
489,960
-41,350
-8% -$1.13M
HPP
172
Hudson Pacific Properties
HPP
$726M
$15.8M 0.23%
89,440
-21,019
-19% -$3.58M
TFX icon
173
Teleflex
TFX
$5.89B
$15.7M 0.23%
43,206
-11,913
-22% -$4.12M
SKYW icon
174
Skywest
SKYW
$4.21B
$15.7M 0.23%
480,757
-64,184
-12% -$1.9M
BLK icon
175
Blackrock
BLK
$178B
$15.7M 0.23%
28,803
-2,288
-7% -$1.16M
5 6
7
8 9

Similar funds

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Rothschild & Co Asset Management US's Q2 2020 Portfolio in Review

As of Q2 2020, Rothschild & Co Asset Management US held 361 positions worth $6.79B, up 5.9% from $6.41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Rothschild & Co Asset Management US withdrew a net $743M in Q2 2020, closing 46 positions and reducing 180 holdings. Its most notable exit was Gilead Sciences, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Rothschild & Co Asset Management US opened a new position in AbbVie worth $56.6M.

  • Rothschild & Co Asset Management US's largest Q2 2020 buy was AbbVie: 576,811 shares worth $56.6M.
  • Rothschild & Co Asset Management US added most to Parker-Hannifin in Q2 2020, an estimated $41M increase.
  • Rothschild & Co Asset Management US's biggest Q2 2020 reduction was Procter & Gamble, cutting an estimated $56M.
  • Rothschild & Co Asset Management US fully exited Gilead Sciences in Q2 2020, selling an estimated $48.6M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $6.79B portfolio in Q2 2020.
  • Rothschild & Co Asset Management US opened 33 new positions and closed 46 in Q2 2020.
  • Rothschild & Co Asset Management US's portfolio value rose 5.9% quarter-over-quarter to $6.79B.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.